European Patent Office

T 1006/21 (B7-H1 in RCC/MAYO FOUNDATION) vom 30.01.2024

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2024:T100621.20240130
Datum der Entscheidung
30. Januar 2024
Aktenzeichen
T 1006/21
Antrag auf Überprüfung von
-
Anmeldenummer
05808659.6
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden verteilt (C)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
Zusammenfassung von Art 13(2) RPBA 2020
Bezeichnung der Anmeldung
B7-H1 and PD-1 in treatment of renal cell carcinoma
Name des Antragstellers
Mayo Foundation for Medical Education and Research
Name des Einsprechenden
Merck Sharp & Dohme LLC
Janssen Biotech, Inc.
Kammer
3.3.08
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 111(1)European Patent Convention Art 56European Patent Convention Art 87(1)Rules of procedure of the Boards of Appeal 2020 Art 011
Schlagwörter
Inventive step - (no)
Priority - same invention (no)
Remittal - (no)
Orientierungssatz
1. The discretionary decision under Article 111(1) EPC to remit a case or not is to be taken ex officio, at any time during the appeal proceedings. It is not dependent on any request by a party. A request for remittal made by a party is therefore not subject to the provisions of Articles 12 and 13 RPBA 2020 (points 23 and 24 of the Reasons).
2. Articles 12 and 13 RPBA 2020 serve to take account of changes in the facts or the subject-matter of the appeal proceedings ("amendments" within the meaning of Articles 12(4) and 13(1) and (2) RPBA), within narrow limits (point 25 of the Reasons).
3. Procedural requests are not amendments within the meaning of Articles 12(4) and 13(1) and (2) RPBA. They can therefore be made at any time during the appeal proceedings and must be considered by the board, regardless of when they are made (points 26 to 29 of the Reasons).

Order

For these reasons it is decided that:

The appeal is dismissed.